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*Klebsiella pneumoniae* is a Gram-negative, nonmotile, and capsule-forming bacterium that frequently causes nosocomial infections ([@B1], [@B2]). It is a member of a group of bacterial pathogens known as ESKAPE (*Enterococcus faecium, Staphylococcus aureus, K. pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa*, and *Enterobacter* species) ([@B3]), all of which are multidrug resistant and responsible for a majority of hospital-acquired infections. Strains often exhibit resistance to carbapenems, which have a broad spectrum of activity and are reserved as drugs of last resort, and these strains are becoming increasingly common ([@B4]). The therapeutic options for infections caused by these microbes are limited; therefore, there is an urgent need to develop novel treatment strategies to complement the current antimicrobial therapies to battle such broad-range antibiotic-resistant pathogens ([@B5][@B6][@B8]).

Whole-genome sequence analysis enables the identification of the molecular basis of antibiotic resistance and facilitates a survey for virulence determinants that can be targeted to reduce the pathogenic effects of the clinical isolates in different models of infection ([@B9][@B10][@B11]). To this end, we sequenced the genomes of five clinical isolates of *K. pneumoniae* isolated from patients in a Chicago area hospital.

Total genomic DNA was extracted with the QIAamp DNA minikit, according to the manufacturer's protocol, and the genomic library was prepared with the TruSeq PCR-free kit with single indexing ([@B12][@B13][@B14]). The genomes were sequenced on the Illumina MiSeq platform using a paired-end library with 250-bp read length and assembled into draft genomes with SPAdes 3.5.0 ([@B15]). The average G+C content was 57.3%, and the total genome length varied between 5.3 and 5.9 Mbp, which is in accordance with reports for other *K. pneumoniae* genomes and is indicative of the varied mobilome of this species ([@B9]). Contigs were annotated using Prokka genome annotation version 1.0.0 ([@B16]), predicting on average 5,451 coding sequences, 77 tRNAs, and 7 rRNAs. Annotation revealed the presence of genes associated with a type VI secretion in all genomes ([@B17], [@B18]), while none of the isolates featured virulence factors related to the mucoid phenotype, *rmpA* ([@B19]) or *magA* ([@B20]), when queried against the UniProt database ([@B21], [@B22]). According to ResFinder ([@B23]), all isolates are multidrug resistant and carry resistance loci, e.g., those against aminoglycosides, β-lactams, fluoroquinolones, and sulfonamides, a finding consistent with the strains' recorded antibiotic resistance phenotypes.

Except for K1, all strains harbor a carbapenemase that was found neighboring transposase genes. Carbapenemase and multiple β-lactam-gene-positive contigs showed high homology (\>99% identity) to various plasmids previously described in *K. pneumoniae* ([@B24]). Understanding the evolutionary origin of the acquisition of the *K. pneumoniae* resistance gene complement will help track the spread of antibiotic resistance among clinical isolates. Future genome-wide association studies utilizing the catalogued genomic plasticity and antibiotic resistance phenotypes will assist in better defining the pathogenic potential of individual isolates in different models of infection ([@B25], [@B26]).
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The annotated draft genome sequences for *K. pneumoniae* strains K1, OC217, OC511, OC648, and Z3209 have been deposited in GenBank under accession numbers [LOEJ00000000](LOEJ00000000), [LOEF00000000](LOEF00000000), [LOEI00000000](LOEI00000000), [LOEH00000000](LOEH00000000), and [LOEG00000000](LOEG00000000), respectively.
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